What Is a Trial Transaction and How Does It Reduce Transaction Risk?

Trial transactions commonly appear as earn-out provisions, contingent purchase agreements, and phased acquisitions. In an earn-out model, the seller receives additional compensation if the acquired business meets specified revenue, profit, or operational targets over a defined period, typically one to three years. Contingent purchase agreements tie closing or final payment to the satisfaction of conditions such as customer retention, regulatory approval, or balance sheet thresholds at a measurement date. Phased acquisitions involve an initial minority or controlling stake purchase with contractual options to acquire remaining equity once performance metrics are satisfied. Each structure creates different accounting treatment, potential earnout disputes, and working capital adjustment challenges that courts and arbitrators must interpret when parties disagree on measurement or achievement of milestones.

Performance metrics must be specific, measurable, and tied to auditable financial or operational data to avoid disputes when the trial period ends. Rather than vague language such as satisfactory performance, effective metrics reference GAAP-compliant earnings, customer churn rates, contract renewal percentages, or regulatory compliance certifications that can be objectively verified. From a practitioner's perspective, the contract should designate which party controls the measurement process, what accounting adjustments are permitted, and how disagreements over calculations are resolved. Courts in New York often encounter earnout disputes where the buyer claims the seller failed to meet targets, while the seller argues the buyer deliberately undermined performance to reduce the earnout payment; clear pre-dispute procedures such as third-party accounting review or expedited arbitration can prevent costly litigation. The contract should also address whether the trial period continues if conditions are partially met, whether performance measurement uses trailing twelve-month data or calendar-year figures, and whether extraordinary events such as supply chain disruptions or market downturns excuse performance shortfalls.

Operational control during the trial period typically remains with the acquired company's existing management unless the purchase agreement explicitly transfers authority to the buyer or establishes a joint governance structure. If the buyer assumes operational control immediately, the seller loses visibility into how the business is managed and may claim later that poor decisions caused performance targets to be missed. Conversely, if the seller retains day-to-day control, the buyer cannot implement cost reductions or strategic changes that might improve the business and justify a higher earnout payment. The contract should specify which decisions require unanimous consent (capital expenditures, key employee terminations, customer contract modifications), which decisions the buyer can make unilaterally (pricing, marketing spend), and which decisions the seller controls (dividend distributions, related-party transactions). This allocation prevents the buyer from deliberately starving the business of resources to suppress earnout payments and prevents the seller from extracting cash that impairs the business's ability to meet targets.

For the seller, earnout payments may be taxed as capital gains or ordinary income depending on whether they are treated as contingent purchase price or as post-closing employment or non-compete payments. For the buyer, earnout liabilities are recorded as contingent consideration and remeasured at fair value each reporting period, creating earnings volatility if the likelihood of payment changes. When parties structure trial transactions as asset purchases versus stock purchases, or when they use earn-outs in conjunction with industrial real estate transactions or aircraft transactions, the tax and accounting treatment differs materially. Corporations should engage tax counsel and accounting advisors early to model the after-tax proceeds, understand how contingent payments affect financial statement presentation, and ensure the contract's measurement and payment terms align with the intended tax classification.

Disputes over earnout calculations or performance achievement are among the most frequent sources of post-closing litigation in trial transactions. The contract should establish a multi-step resolution process: first, a calculation review by each party's accountant; second, if those accountants disagree, engagement of an independent third-party accounting firm to make a binding determination; and third, if the dispute involves contract interpretation rather than calculation, referral to expedited arbitration rather than court litigation. This tiered approach reduces delays and legal costs compared to immediate court proceedings. The contract should also specify whether earnout disputes are resolved using the measurement methodology in place at closing or whether later accounting restatements trigger recalculation of the earnout payment. Without these procedures in place, parties often find themselves in protracted discovery disputes in New York state or federal court, with each side hiring competing accounting experts and the core business integration suffering from management distraction and uncertainty.

Corporations entering trial transactions should prioritize detailed contract drafting that defines performance metrics with precision, allocates operational control clearly, establishes objective measurement procedures, and creates tiered dispute resolution mechanisms before the trial period begins. Early engagement with tax counsel to model earnout tax treatment and with accounting advisors to confirm financial statement presentation avoids costly surprises. Documenting baseline performance data, customer contracts, and employee arrangements at closing creates the factual record necessary to defend earnout calculations or support a claim that the buyer undermined performance. These foundational steps do not guarantee that the trial transaction will proceed to full acquisition, but they materially reduce the risk that disputes over measurement, control, or performance will derail the evaluation process or generate post-closing litigation.